Medicare Enrollment Blitz Doesn’t Include Options to Move Into Medigap
(By Harris Meyer for Kaiser Health News) Medicare’s annual open-enrollment season is here and millions of beneficiaries — prompted by
Read More
Part D/Prescription Drugs
Cost and controversy are limiting use of new Alzheimer’s drug
(By Jon Hamilton for NPR) The new Alzheimer’s drug Aduhelm isn’t reaching many patients. And doctors say reasons include its
Read MoreExperimental Pfizer pill prevents Covid hospitalizations and deaths
(By Matthew Herper for STAT) An experimental antiviral pill developed by Pfizer reduced the risk of death and hospitalization by
Read MoreHours after the White House issues its new vaccine mandate, GOP-led states sue
(By Jaclyn Diaz for NPR) The chief law enforcement officials for Kentucky, Tennessee and Ohio are challenging the Biden administration’s mandate requiring federal
Read MoreA Record 3,834 Medicare Advantage Plans Will be Available in 2022, Up 8 Percent From 2021, While the Number of Medicare Part D Stand-Alone Plans is Decreasing Mainly Due to Firm Consolidations
(Source – Kaiser Family Foundation published November 2, 2021) A record 3,834 Medicare Advantage plans will be available across the
Read MoreHere’s who wins and loses in Democrats’ new prescription drug pricing deal
(By Rachel Cohrs for STAT) WASHINGTON — Congressional Democrats on Tuesday announced they had agreed to a broad plan to
Read MoreMedicare Part D: A First Look at Medicare Prescription Drug Plans in 2022
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation published November 2, 2021) During the Medicare open enrollment period
Read MoreNursing Home Residents Overlooked in Scramble for Covid Antibody Treatments
(By JoNel Aleccia for Kaiser Health News) Of the dozens of patients Dr. Jim Yates has treated for covid-19 at
Read MoreA cheap antidepressant is showing promise treating COVID-19 in high-risk adults
(NPR) A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing
Read MoreMerck will allow drugmakers in other countries to make its COVID-19 pill
(By Scott Neuman for NPR) U.S.-based pharmaceutical giant Merck & Co. said it will license drugmakers worldwide to produce its potentially
Read More